Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

BMPR-1A inhibition by RAP-661 increases bone mass and strength in mice

Oct. 28, 2010

Intravenous zanamivir administration is feasible in patients with severe flu

Oct. 28, 2010

Recent preclinical studies offer insight into mechanism of action of laquinimod

Oct. 28, 2010

New clinical data presented on anticancer agents GSK-2118436 and GSK-1120212

Oct. 28, 2010

Second dose enhances immunogenicity of MenACWY-TT flu vaccine in toddlers

Oct. 28, 2010

CD56(bright) NK cell count predicts response to daclizumab in relapsing-remitting MS

Oct. 28, 2010

Combination of BG-12 with IFN-beta 1a or glatiramer acetate is safe in healthy subjects

Oct. 27, 2010

BMS-690514 shows potential to treat non-small cell lung cancer

Oct. 27, 2010

GM-CSF adjuvant enhances efficacy of AIDS vaccine in rhesus macaques

Oct. 27, 2010

Long-term data disclosed on alemtuzumab for treatment of relapsing-remitting MS

Oct. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...